Hipromine SA
WSE:HPM
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
182
278
|
| Price Target |
|
We'll email you a reminder when the closing price reaches PLN.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Hipromine SA
Cash & Cash Equivalents
Hipromine SA
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Hipromine SA
WSE:HPM
|
Cash & Cash Equivalents
zł15.8m
|
CAGR 3-Years
67%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
W
|
Wawel SA
WSE:WWL
|
Cash & Cash Equivalents
zł290.4m
|
CAGR 3-Years
15%
|
CAGR 5-Years
14%
|
CAGR 10-Years
10%
|
|
|
T
|
Tarczynski SA
WSE:TAR
|
Cash & Cash Equivalents
zł22.4m
|
CAGR 3-Years
13%
|
CAGR 5-Years
18%
|
CAGR 10-Years
17%
|
|
|
Z
|
Zaklady Przemyslu Cukierniczego Otmuchow SA
WSE:OTM
|
Cash & Cash Equivalents
zł7.5m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
9%
|
CAGR 10-Years
6%
|
|
|
G
|
Gobarto SA
WSE:GOB
|
Cash & Cash Equivalents
zł60.6m
|
CAGR 3-Years
33%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
|
|
M
|
Makarony Polskie SA
WSE:MAK
|
Cash & Cash Equivalents
zł43.8m
|
CAGR 3-Years
317%
|
CAGR 5-Years
172%
|
CAGR 10-Years
37%
|
|
Hipromine SA
Glance View
HiProMine SA engages in the provision of innovative technology for industrial scale of insect breeding and processing. The firm is engaged in production of protein products for pet food and fodder for fish farming based on industrial insects breeding. The company provides its products from production process to the final product.
See Also
What is Hipromine SA's Cash & Cash Equivalents?
Cash & Cash Equivalents
15.8m
PLN
Based on the financial report for Dec 31, 2023, Hipromine SA's Cash & Cash Equivalents amounts to 15.8m PLN.
What is Hipromine SA's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 3Y
67%
Over the last year, the Cash & Cash Equivalents growth was 164%. The average annual Cash & Cash Equivalents growth rates for Hipromine SA have been 67% over the past three years .
You don't have any saved screeners yet